+91-9561854529 editorinchief.ijama@gmail.com submitpaper@ijama.in Contact Form

Artificial Intelligence in Healthcare: Transforming Diagnosis, Treatment, and Patient Outcomes

Author(s):Ramani Kala

Affiliation: Research Fellow, Institute for Digital Medicine

Page No: 31-34

Volume issue & Publishing Year: Volume 3, Issue 6, June 2026

published on: 2026/06/07

Journal: International Journal of Advanced Multidisciplinary Application.(IJAMA)

ISSN NO: 3048-9350

DOI:

Download PDF

Abstract:
Artificial Intelligence (AI) is reshaping the healthcare landscape at an unprecedented pace. From early disease detection powered by deep learning algorithms to precision medicine tailored to individual genetic profiles, AI technologies are delivering measurable improvements in patient outcomes, operational efficiency, and medical research. This article presents a comprehensive analysis of AI applications across diagnostic imaging, drug discovery, clinical decision support, and hospital administration—drawing on peer-reviewed research, industry data, and real-world case studies. The article also addresses ethical considerations, data privacy concerns, and the path toward equitable, responsible AI deployment in global health systems.

Keywords: Artificial Intelligence , Healthcare

Reference:

  • 1. McKinney, S.M. et al. (2020). International evaluation of an AI system for breast cancer screening. Nature Medicine, 26, 814–822.
  • 2. De Fauw, J. et al. (2018). Clinically applicable deep learning for diagnosis and referral in retinal disease. Nature Medicine, 24, 1342–1350.
  • 3. Grand View Research. (2025). Artificial Intelligence in Healthcare Market Size & Trends Report. San Francisco: GVR.
  • 4. Topol, E.J. (2023). The Creative Destruction of Medicine (2nd ed.). New York: Basic Books.
  • 5. Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019). Dissecting racial bias in an algorithm used to manage the health of populations. Science, 366(6464), 447–453.
  • 6. FDA. (2024). Artificial Intelligence and Machine Learning in Software as a Medical Device. US Food and Drug Administration.
  • 7. European Parliament. (2024). Regulation (EU) 2024/1689 — Artificial Intelligence Act. Official Journal of the European Union.
  • 8. Insilico Medicine. (2021). AI-discovered drug candidate for fibrosis enters Phase I clinical trials. Nature Biotechnology, 39, 1398–1405.